Ranimerck en es it fr

Ranimerck Brand names, Ranimerck Analogs

Ranimerck Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranimerck Chemical_Formula


Ranimerck RX_link


Ranimerck fda sheet

Ranimerck FDA

Ranimerck msds (material safety sheet)

Ranimerck MSDS

Ranimerck Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranimerck Molecular Weight

314.405 g/mol

Ranimerck Melting Point

69-70 oC

Ranimerck H2O Solubility

24.7 mg/mL

Ranimerck State


Ranimerck LogP


Ranimerck Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranimerck Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranimerck Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranimerck Absorption

Approximately 50% bioavailability orally.

Ranimerck side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranimerck Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranimerck Organisms Affected

Humans and other mammals